The in vitro antibacterial activity of the antifungal compound fenticonazole was compared with those of clotrimazole, miconazole, tetracycline, and metronidazole against 177 strains of bacterial species associated with either bacterial vaginosis (BV) In initial studies it was reported that fenticonazole is also active against some bacteria, particularly staphylococci, and it was thought that it may have useful roles in mycotic infections superinfected with bacteria and in vaginal infections, in which activity against C. albicans and the organisms associated with bacterial vaginosis (BV), Gardnerella vaginalis, Mobiluncus spp., Bacteroides spp., and anaerobic gram-positive cocci, could be appropriate for empiric treatment.
Fenticonazole is a new imidazole derivative that was developed for the topical treatment of fungal infections by Recordati S.p.A. (Milan, Italy) . It is reported to be a safe, well-tolerated compound with good in vitro and in vivo activities against dermatophyte pathogens such as Microsporum, Epidermophyton, and Trichophyton spp. and against Candida albicans in patients with vaginal candidiasis (May and Baker Ltd., personal communication).
In initial studies it was reported that fenticonazole is also active against some bacteria, particularly staphylococci, and it was thought that it may have useful roles in mycotic infections superinfected with bacteria and in vaginal infections, in which activity against C. albicans and the organisms associated with bacterial vaginosis (BV), Gardnerella vaginalis, Mobiluncus spp., Bacteroides spp., and anaerobic gram-positive cocci, could be appropriate for empiric treatment.
Therefore, we undertook this study to compare, in vitro, (i) the activities of fenticonazole, clotrimazole, miconazole, and metronidazole against the organisms associated with BV and (ii) the activity of the imidazole compounds and tetracycline against organisms associated with skin infections.
Fenticonazole The test strains were grown on DST agar for 24 to 48 h (the longer period was used for slow-growing strains), and the growth was harvested into sterile saline. These suspensions were then diluted to a concentration of 109 CFU/ml, which was determined by comparison with match-opacity tubes (Wellcome Diagnostics, Dartford, United Kingdom) that were previously calibrated in this laboratory (3) . A multipoint inoculator (Denley Instruments Ltd., Billinghurst, United Kingdom) was used to deliver 0.001-ml inocula ( 
